Verizon Business selected to transform Astellas Pharma

TOKYO, Aug. 09, 2022 (GLOBE NEWSWIRE) — Verizon Business has been selected to manage the global network infrastructure of Astellas Pharma Inc (Astellas). The network transformation will allow Astellas to leverage advanced technologies to help reduce drug development times, healthcare costs and generate new revenue opportunities for the Japanese multinational pharmaceutical company.

Headquartered in Tokyo, Japan, Astellas is a global pharmaceutical company involved in the research, development, manufacturing and commercialization of innovative new medicines under the vision of “Standing at the forefront of healthcare change”. to turn innovative science into VALUE for patients”. The company employs 14,000 people worldwide.

The company has identified digital transformation as a key driver of its business growth and has begun the search for a global partner to transform all aspects of its global technology infrastructure, including building, designing and executing a next-generation secure network. In particular, Astellas was looking for a scalable and predictable platform that could seamlessly manage tens of thousands of devices and endpoints across more than 70 Astellas global locations in a virtualized multi-source environment.

Verizon’s relationship with Astellas dates back more than a decade. In 2016, Astellas successfully deployed Verizon’s Secure Cloud Interconnect (SCI) to provide a secure, high-speed connection to its Amazon Web Services (AWS) and Microsoft Azure cloud services. Verizon’s current mission includes building and deploying Astellas’ global integrated network with a full suite of managed services, including Managed WAN, LAN, Managed Security Services (MSS), Secure Gateway, Network Access and Unified Communications and Collaboration as a Service.

Shinya Suda, Senior Vice President, Information Systems, Astellas, said, “From R&D to sales, we see tremendous amounts of data and intelligence flowing through our business, across our 70 locations around the world. . We want to ensure that we have a scalable network to use advanced technologies such as artificial intelligence, machine learning and robotics to make data-driven decisions to deliver better value to our patients. The transformation of our network will support the next phase of our growth. »

“The network is transformative in its ability to enable innovation and growth and Astellas is changing the way they use the tools at their disposal to completely revolutionize their business. This is truly a watershed moment for the pharmaceutical industry as Companies are grappling with pressure to reduce drug development time and costs while improving patient care and value. We are proud to have been part of Astellas’ growth journey for more than a decade.” , said Robert LeBusqueRegional Vice President, Verizon Business Group, Asia Pacific.

Today’s announcement builds on the company’s network-as-a-service foundation and supports its private networks, mobile edge computing, and enterprise solutions growth drivers.

Verizon Communications Inc. (NYSE, Nasdaq: VZ) was established on June 30, 2000 and is one of the world’s leading providers of technology and communications services. Headquartered in New York and operating globally, Verizon generated revenues of $133.6 billion in 2021. The company provides data, video and voice services and solutions across its award-winning networks and platforms, meeting customer demand for mobility, reliable network connectivity, security and control.

VERIZON ONLINE MEDIA CENTER: Press releases, articles, media contacts and other resources are available at verizon.com/news. Press releases are also available via an RSS feed. To subscribe, visit www.verizon.com/about/rss-feeds/.

Media contact:
Nilesh Pritam
[email protected]
+65.9277.9048